Healthcare -
Biotechnology - NASDAQ - US
$ 43.33
-0.161 %
$ 4 B
Market Cap
-6.82
P/E
RARE - OTHER LONG-TERM ASSETS
Other Long-term Assets RARE - Ultragenyx Pharmaceutical Inc.
57.7 M
LAST VALUE
122.84%
2 YEAR CAGR
75.01%
5 YEAR CAGR
33.96%
10 YEAR CAGR